Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 352

1.

Thyroid hormones for acute kidney injury.

Nigwekar SU, Strippoli GF, Navaneethan SD.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD006740. doi: 10.1002/14651858.CD006740.pub2. Review.

PMID:
23440810
2.

Intensity of continuous renal replacement therapy for acute kidney injury.

Fayad AI, Buamscha DG, Ciapponi A.

Cochrane Database Syst Rev. 2016 Oct 4;10:CD010613. Review.

PMID:
27699760
3.

HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.

Lewicki M, Ng I, Schneider AG.

Cochrane Database Syst Rev. 2015 Mar 11;(3):CD010480. doi: 10.1002/14651858.CD010480.pub2. Review.

PMID:
25758322
4.

Atrial natriuretic peptide for preventing and treating acute kidney injury.

Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006028. doi: 10.1002/14651858.CD006028.pub2. Review.

PMID:
19821351
5.

Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.

Mutter TC, Ruth CA, Dart AB.

Cochrane Database Syst Rev. 2013 Jul 23;(7):CD007594. doi: 10.1002/14651858.CD007594.pub3. Review.

PMID:
23881659
6.

Bicarbonate- versus lactate-buffered solutions for acute continuous haemodiafiltration or haemofiltration.

Tian JH, Ma B, Yang K, Liu Y, Tan J, Liu TX.

Cochrane Database Syst Rev. 2015 Mar 5;(3):CD006819. doi: 10.1002/14651858.CD006819.pub2. Review.

PMID:
25740673
7.

Tidal versus other forms of peritoneal dialysis for acute kidney injury.

Jiang L, Zeng R, Yang K, Mi DH, Tian JH, Ma B, Liu Y.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD007016. doi: 10.1002/14651858.CD007016.pub2. Review.

PMID:
22696364
8.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 Jan 28;(1):CD005019. doi: 10.1002/14651858.CD005019.pub4. Review.

PMID:
24470059
9.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 May 31;(5):CD007784. doi: 10.1002/14651858.CD007784.pub2. Review.

PMID:
24880031
10.

Oral adsorbents for preventing or delaying the progression of chronic kidney disease.

Wu HM, Sun HJ, Wang F, Yang M, Dong BR, Liu GJ.

Cochrane Database Syst Rev. 2014 Oct 15;(10):CD007861. doi: 10.1002/14651858.CD007861.pub2. Review.

PMID:
25317905
11.

Immunosuppressive agents for treating IgA nephropathy.

Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF.

Cochrane Database Syst Rev. 2015 Aug 3;(8):CD003965. doi: 10.1002/14651858.CD003965.pub2. Review.

PMID:
26235292
12.

Pentoxifylline for diabetic kidney disease.

Shan D, Wu HM, Yuan QY, Li J, Zhou RL, Liu GJ.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD006800. doi: 10.1002/14651858.CD006800.pub2. Review.

PMID:
22336824
13.

Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation.

Wang L, Li X, Yang Z, Tang X, Yuan Q, Deng L, Sun X.

Cochrane Database Syst Rev. 2016 Jan 8;(1):CD009946. doi: 10.1002/14651858.CD009946.pub2. Review.

PMID:
26743945
14.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
15.

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.

Chen Y, Schieppati A, Chen X, Cai G, Zamora J, Giuliano GA, Braun N, Perna A.

Cochrane Database Syst Rev. 2014 Oct 16;(10):CD004293. doi: 10.1002/14651858.CD004293.pub3. Review.

PMID:
25318831
16.

Antioxidants for chronic kidney disease.

Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, Webster AC, Perkovic V.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD008176. doi: 10.1002/14651858.CD008176.pub2. Review.

PMID:
23076940
17.

Lipid-lowering agents for nephrotic syndrome.

Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.

Cochrane Database Syst Rev. 2013 Dec 10;(12):CD005425. doi: 10.1002/14651858.CD005425.pub2. Review.

PMID:
24327265
18.

Continuous renal replacement therapy (CRRT) for rhabdomyolysis.

Zeng X, Zhang L, Wu T, Fu P.

Cochrane Database Syst Rev. 2014 Jun 15;(6):CD008566. doi: 10.1002/14651858.CD008566.pub2. Review.

PMID:
24929959
19.

Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients.

Penninga L, Wettergren A, Wilson CH, Chan AW, Steinbr├╝chel DA, Gluud C.

Cochrane Database Syst Rev. 2014 Jun 5;(6):CD010253. doi: 10.1002/14651858.CD010253.pub2. Review.

PMID:
24901467
20.

Interventions for chronic kidney disease-associated restless legs syndrome.

Gopaluni S, Sherif M, Ahmadouk NA.

Cochrane Database Syst Rev. 2016 Nov 7;11:CD010690. Review.

PMID:
27819409

Supplemental Content

Support Center